Table 1 SPRS, SARA, DSI-ARSACS, 10MWT and 6MWT scores in patients 1 and 2 before starting DHA and after 6, 12 and 20 months of DHA treatment
From: Docosahexaenoic acid in ARSACS: observations in two patients
P1 | P2 | |||||||
|---|---|---|---|---|---|---|---|---|
T0 | 6 mo | 12 mo | 20 mo | T0 | 6 mo | 12 mo | 20 mo | |
SPRS | 16 | 17 | 15.5 | 13 | 12 | 9.5 | 10 | 10 |
SARA | 7 | 8.75 | 11.5 | 8 | 9 | 7.5 | 11 | 8 |
DSI-ARSACS | 11 | 9.5 | 7.5 | 9.5 | 9 | 9.5 | 8.5 | 9.5 |
10MWT (sec) | 15.8 | 14.2 | 13.8 | 15.4 | 9.9 | 9.2 | 9.6 | 9.8 |
6MWT (m) | 252 | 253 | 264 | 250 | 400 | 475 | 434 | 434.5 |